Real-world evidence on the effectiveness and safety of gliclazide MR 60 mg in Bangladeshi patients with Type II diabetes during fasting: a sub-analysis from the global DIA-RAMADAN study

• Auteurs principaux: Mohammed Farid Uddin (Auteur), Murshed Ahamed Khan (Auteur), Shahjada Selim (Auteur), Nusrat Sultana (Auteur), Mohammad Abu Sayem (Auteur), Mohammed Mahboob Iftekhar (Auteur), Maruf Bin Habib (Auteur), Nazma Akter (Auteur), Shahjamal Khan (Auteur)
• Format: Livre
• Publié: Becaris Publishing Limited, 2024-01-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Aim: Many Muslims with Type II diabetes (T2DM) fast during Ramadan, which can put them at increased risk of hypoglycemia. This sub-analysis of the global DIA-RAMADAN study assessed the effectiveness and safety of gliclazide modified release (MR) 60 mg in the Bangladeshi cohort. Materials & metho...